HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Molecular Biology

• Publication date

  2011-10-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.jmb.2011.08.012PMID 21856311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteins.

  2010cited by this paper
• Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire

  2009cited by this paper
• A novel solid phase technology for high-throughput gene synthesis.

  2008cited by this paper
• In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification.

  2008cited by this paper
• Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens.

  2008cited by this paper
• Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

  2008cited by this paper
• The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.

  2008cited by this paper
• The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries

  2005cited by this paper
• Molecular recognition by a binary code.

  2005cited by this paper
• Characterization of high-affinity antibodies by electrochemiluminescence-based equilibrium titration.

  2005cited by this paper
• Construction, evaluation and refinement of a large human antibody phage library based on the IgD and IgM variable gene repertoire.

  2005cited by this paper
• Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity

  2005cited by this paper
• High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.

  2004cited by this paper
• Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition.

  2004cited by this paper
• Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.

  2004cited by this paper
• VBASE2, an integrative V gene database

  2004cited by this paper
• Analysis of the antigen combining site: correlations between length and sequence composition of the hypervariable loops and the nature of the antigen.

  2003cited by this paper
• Human Combinatorial Fab Library Yielding Specific and Functional Antibodies against the Human Fibroblast Growth Factor Receptor 3*

  2003cited by this paper
• From EST to IHC: human antibody pipeline for target research.

  2003cited by this paper
• Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.

  2003cited by this paper
• Establishment of a human somatic hybrid cell line for recombinant protein production.

  2002cited by this paper
• Functional Consequences of Insertions and Deletions in the Complementarity-determining Regions of Human Antibodies*

  2002cited by this paper
• Establishment of a Human Somatic Hybrid Cell Line for Recombinant Protein Production

  2002cited by this paper
• The mechanism and regulation of chromosomal V(D)J recombination.

  2002cited by this paper
• n-CoDeR concept: unique types of antibodies for diagnostic use and therapy

  2001cited by this paper
• High-throughput generation and engineering of recombinant human antibodies.

  2001cited by this paper
• An oriP expression vector containing the HIV-1 Tat/TAR transactivation axis produces high levels of protein expression in mammalian cells

  2001cited by this paper
• Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides.

  2000cited by this paper
• Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries

  2000cited by this paper
• Preferred CDRH3 lengths for antibodies with defined specificities.

  1998cited by this paper
• Standard conformations for the canonical structures of immunoglobulins.

  1997cited by this paper
• The creation of diversity in the human immunoglobulin Vλ repertoire

  1997cited by this paper
• The creation of diversity in the human immunoglobulin V(lambda) repertoire.

  1997cited by this paper
• Sequence and evolution of the human germline V lambda repertoire.

  1996cited by this paper
• A convenient approach to the synthesis of trinucleotide phosphoramidites--synthons for the generation of oligonucleotide/peptide libraries.

  1996cited by this paper
• Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library

  1996cited by this paper
• Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions.

  1995cited by this paper
• The structural repertoire of the human V kappa domain.

  1995cited by this paper
• Isolation of high affinity human antibodies directly from large synthetic repertoires.

  1994cited by this paper
• Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.

  1994cited by this paper
• Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis.

  1994cited by this paper
• Selection of human anti-hapten antibodies from semisynthetic libraries.

  1993cited by this paper
• Length distribution of CDRH3 in antibodies

  1993cited by this paper
• Structural repertoire of the human VH segments.

  1992cited by this paper
• An artificial immune system for making antibodies.

  1992cited by this paper
• Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding.

  1992cited by this paper
• The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops.

  1992cited by this paper
• By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro.

  1992cited by this paper
• Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem.

  1992cited by this paper
• By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

  1991cited by this paper
• Sequences of proteins of immunological interest

  1991cited by this paper
• Comparison of D, JH, and junctional diversity in the fetal, adult, and aged B cell repertoires.

  1991cited by this paper
• Canonical structures for the hypervariable regions of immunoglobulins.

  1987cited by this paper
• H-Y typing in the ELISA.

  1984cited by this paper
• Somatic generation of antibody diversity

  1983cited by this paper
• Somatic generation of antibody diversity.

  1976cited by this paper

• The Midas touch: Recombinant antibodies transforming diagnostic platforms.

  2026cites this paper
• Energy-guided combinatorial co-optimization of antibody affinity and stability

  2026cites this paper
• A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemia.

  2026cites this paper
• From Phage Surface to Bedside: Development of Therapeutic Monoclonal Antibodies using Phage Display

  2025cites this paper
• A diverse semisynthetic humanized scFv phage display library for anti-CXCL16 antibodies

  2025cites this paper
• Pioneer: a synthetic human antibody phage display library for rapid therapeutic lead generation

  2025cites this paper
• Continuous Protein Sensing Using Fast-Dissociating Antibody Fragments in Competition-Based Biosensing by Particle Motion

  2025cites this paper
• Evolving bioanalytical strategies in the wake of pioneering biotherapeutics.

  2025cites this paper
• Epitope Profiling of SARS-CoV-2 Spike Antigen Provides a Novel Strategy for Developing ELISAs Specific for Different Spike Protein Variants in Bivalent Vaccine Formulations

  2025cites this paper
• Guidelines in the Preparation of Fully Synthetic, Human Single-Domain Antibody Phage Display Libraries

  2025cites this paper
• Discovery of Antibodies Against Endemic Coronaviruses with NGS-Based Human Fab Phage Display Platform

  2025cites this paper
• An iterative strategy to design 4-1BB agonist nanobodies de novo with generative AI models

  2025cites this paper
• Reversible Sandwich‐Based Particle Nanoswitch for Continuous Protein Monitoring at Picomolar Concentrations with Automated Calibration

  2025cites this paper
• 20 Years of Providing Custom Non-Animal-Derived Antibodies — A Review

  2025cites this paper
• Targeting emerging viruses with phage display-driven engineered antibodies: Bridging molecular design and clinical application.

  2025cites this paper
• Structure-based design of antibody repertoires with drug-like properties

  2025cites this paper
• Construction and validation of a synthetic phage-displayed nanobody library

  2024cites this paper
• Considerations for Using Phage Display Technology in Therapeutic Antibody Drug Discovery.

  2024cites this paper
• The development of rapid immunoassays for the urinary analysis of 1-Hydroxypyrene Glucuronide facilitate both laboratory and on-site Polycyclic Aromatic Hydrocarbon biomonitoring.

  2024cites this paper
• Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate

  2024cites this paper
• A review of in vitro stochastic and non-stochastic affinity maturation strategies for phage display derived monoclonal antibodies.

  2024cites this paper
• Engineered reversible inhibition of SpyCatcher reactivity enables rapid generation of bispecific antibodies

  2024cites this paper
• Solving selectivity issues in LBAs: case study using Gyrolab to quantify CB307, a bispecific Humabody in human serum

  2024cites this paper
• Phage display technology and its impact in the discovery of novel protein-based drugs

  2024cites this paper
• Combining Cellular Immunization and Phage Display Screening Results in Novel, FcγRI-Specific Antibodies

  2024cites this paper
• Structural Survey of Antigen Recognition by Synthetic Human Antibodies.

  2024cites this paper
• Monoclonal Antibody Development for Cancer Treatment Using the Phage Display Library Platform

  2024cites this paper
• Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair

  2024cites this paper
• Phage-derived anti-idiotype and anti-YTE antibodies in development of MK-1654 pharmacokinetic and immune response assays.

  2023cites this paper
• Protein engineering via sequence-performance mapping.

  2023cites this paper
• Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening

  2023cites this paper
• Evolution of phage display libraries for therapeutic antibody discovery

  2023cites this paper
• Modular antibodies reveal DNA damage-induced mono-ADP-ribosylation as a second wave of PARP1 signaling

  2023cites this paper
• Highly reliable GIGA-sized synthetic human therapeutic antibody library construction

  2023cites this paper
• Eliminating OFF-Frame Clones in Randomized Gene Libraries: An Improved Split β-Lactamase Enrichment System.

  2023cites this paper
• Review of phage display: A jack-of-all-trades and master of most biomolecule display.

  2023cites this paper
• Antibody Selection via Phage Display in Microtiter Plates.

  2023cites this paper
• A Novel Synthetic Antibody Library with Complementarity-Determining Region Diversities Designed for an Improved Amplification Profile

  2022cites this paper
• Reconstruction of full antibody sequences in NGS datasets and accurate VL:VH coupling by cluster coordinate matching of non-overlapping reads

  2022cites this paper
• An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages.

  2022cites this paper
• Development of humanised antibodies for Crimean-Congo Haemorrhagic fever virus: Comparison of hybridoma-based versus phage library techniques.

  2022cites this paper
• Leveraging monoclonal antibodies as therapeutics to address antimicrobial resistance in bacteria

  2022cites this paper
• Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics

  2022cites this paper
• A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies

  2022cites this paper
• In vivo Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery properties

  2022cites this paper
• Sensitizing Staphylococcus aureus to antibacterial agents by decoding and blocking the lipid flippase MprF

  2022influential citation
• An in silico method to assess antibody fragment polyreactivity

  2022cites this paper
• Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus Immunotherapeutic

  2022cites this paper
• Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children

  2022cites this paper
• Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display

  2022cites this paper
• Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries

  2021cites this paper
• Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy

  2021cites this paper
• Retrospective feasibility study of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children

  2021cites this paper
• Evolving Antibody Therapies for the Treatment of Type 1 Diabetes

  2021cites this paper
• Recombinant Anti-idiotypic Antibodies in Ligand Binding Assays for Antibody Drug Development.

  2021cites this paper
• Phage Display Technology as a Powerful Platform for Antibody Drug Discovery

  2021cites this paper
• Antibody display technologies: selecting the cream of the crop

  2021cites this paper
• A single donor is sufficient to produce a highly functional in vitro antibody library

  2021cites this paper
• Engineering Antibody-Based Therapeutics: Progress and Opportunities

  2021cites this paper
• Generation of mAb Variants with Less Attractive Self-Interaction but Preserved Target Binding by Well-Directed Mutation.

  2020cites this paper
• Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies

  2020cites this paper
• Phage Display Derived Monoclonal Antibodies: From Bench to Bedside

  2020cites this paper
• An efficient ORF selection system for DNA fragment libraries based on split beta-lactamase complementation

  2020cites this paper
• How repertoire data are changing antibody science

  2020cites this paper
• Split & mix assembly of DNA libraries for ultrahigh throughput on-bead screening of functional proteins

  2020cites this paper
• Monoclonal antibodies: A prospective and retrospective view.

  2020cites this paper
• Current Applications of Pharmaceutical Biotechnology

  2020cites this paper
• Developability in biophysical characterization

  2020cites this paper
• Periplasmic Expression of SpyTagged Antibody Fragments Enables Rapid Modular Antibody Assembly

  2020cites this paper
• Chemical Diversification of Simple Synthetic Antibodies.

  2020cites this paper
• Sensitizing Staphylococcus aureus to antibacterial host defense by decoding and blocking the lipid flippase MprF

  2020influential citation
• Direct Kinetic Fingerprinting for High-Accuracy Single-Molecule Counting of Diverse Disease Biomarkers.

  2020cites this paper
• Decoding and blocking the bacterial lipid flippase MprF yields a novel anti-virulence strategy

  2020influential citation
• An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation.

  2020cites this paper
• Development of a novel mammalian display system for selection of antibodies against membrane proteins

  2020cites this paper
• Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of Vibrio cholerae O1 from Phage-Displayed Human Synthetic Fab Library

  2020cites this paper
• Direct kinetic fingerprinting and digital counting of single protein molecules

  2020cites this paper
• Cognizance of Molecular Methods for the Generation of Mutagenic Phage Display Antibody Libraries for Affinity Maturation

  2019cites this paper
• Therapeutic Antibody Engineering and Selection Strategies.

  2019cites this paper
• Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputs

  2019cites this paper
• Exploring the Complex Folding Free Energy Landscapes of a Series of β-rich Proteins

  2019cites this paper
• A cross-reactive monoclonal antibody as universal detection antibody in autoantibody diagnostic assays.

  2019cites this paper
• Phage Display Libraries for Antibody Therapeutic Discovery and Development

  2019influential citation
• Quantifying the nativeness of antibody sequences using long short-term memory networks

  2019cites this paper
• Multifunctional nanomedicine for the intracellular delivery of an antibody to CD44v6 expressing cancer cells

  2019cites this paper
• Display Technologies for the Selection of Monoclonal Antibodies for Clinical Use

  2018cites this paper
• Monoclonal antibodies: technologies for early discovery and engineering

  2018cites this paper
• Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy

  2018cites this paper
• Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries.

  2018cites this paper
• Computational design of antibodies.

  2018cites this paper
• Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.

  2018cites this paper
• High Affinity Maturated Human Antibodies from Naïve and Synthetic Antibody Repertoires

  2018cites this paper
• Phage Display Technology for Human Monoclonal Antibodies.

  2018cites this paper
• Generation by phage display and characterization of drug-target complex-specific antibodies for pharmacokinetic analysis of biotherapeutics

  2018cites this paper
• Colony Assay for Antibody Library Screening: Outlook and Comparison to Display Screening

  2018cites this paper
• NEXT-GENERATION SEQUENCING AND MOTIF GRAFTING APPLICATIONS IN SYNTHETIC ANTIBODY DISCOVERY

  2018influential citation
• Phage Display Technology for Selection of Antibody Fragments

  2018cites this paper
• ScienceDirect Computational design of antibod ies

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• An enzyme-linked immunosorbent assay for the detection of diacetyl (2,3-butanedione).

  2017cites this paper